Pfizer Inc. agreed Friday to settle a lawsuit ... Beginning in December 1998 and continuing through March 2001, The Times reported that FDA officials disregarded warnings of danger while approving ...

Pfizer, according to the documents ... seems to have yielded negative results—but when it was published in 2001 in the journal Headache, it was written up with positive ones.

Pfizer is facing a shortage of penicillin due ... Syphilis rates were at a historic low from 2000 to 2001, but have increased every year since, with an increase of 28.6% from 2020 to 2021, which ...

In its statement, Pfizer said the study results were sent to the FDA in the summer of 2001. The company also said that the results of the study were presented in a scientific meeting in 2000.

After a long tug-of-war between the European Commission and The New York Times over transparency surrounding the Pfizer COVID-19 vaccine contracts, the European Court of Justice (ECJ) today ruled that ...

It went public in 2001, pricing its IPO at $7 per share. The new deal values the company at approximately $229 per share, a 33% premium over its closing price Friday. In an investor call ...

Pfizer is spending about $43 billion to acquire ... which was founded in 1997 and went public in 2001. Advertising “This compelling transaction will deliver significant and immediate value ...

Pfizer’s plan to acquire Seagen for $43 billion ... Seagen launched as Seattle Genetics in 1998. It went public in 2001, pricing its IPO at $7 per share. The terms of the acquisition put Seagen ...